Meta-analysis reports substantial global variations in active and lifetime epilepsy prevalence, indicating that study characteristics only partially explain differences in burden estimates.
This study estimates the global burden of epilepsy and the proportions with AE, which may benefit from treatment. There are systematic differences in reported prevalence estimates, which are only partially explained by study characteristics.
No takes yet. Share an insight, caveat, or question.
Ngugi et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: